Justin D. Gover
CIK 1754129 · Chief Executive Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$166.5K
Companies
4
Total Filings
31
Lifetime Open-Market Net
-$8.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DSGN | Director | — | $11.94 | — | $0 | 3 | 2026-06-11 |
| XENE | Director | 2,645 | $62.95 | $166.5K | $0 | 4 | 2026-06-03 |
| CMPS | Director | — | $10.88 | — | $0 | 2 | 2026-05-29 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Chief Executive Officer | 2,131,481 | $218.96 | $466.71M | -$8.20M | 21 | 2021-03-22 |
Recent Filings · Page 3 of 4
31 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-28 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −12,000 | -$108.6K | EDGAR |
| 2020-02-05 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | — | -$1.94M | EDGAR |
| 2019-12-19 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +5,328 | -$49.0K | EDGAR |
| 2019-06-18 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | +16,656 | $22 | EDGAR |
| 2019-05-30 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | — | -$3.08M | EDGAR |
| 2019-03-19 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +24,432 | -$328.0K | EDGAR |
| 2019-03-05 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-28 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +11,328 | -$138.3K | EDGAR |
| 2019-02-15 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −22,620 | -$282.8K | EDGAR |
| 2019-01-04 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −22,620 | -$188.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.